Neurogene logo

Neurogene Share Price (NASDAQ: NGNE)

$18.43

-0.41

(-2.18%)

Last updated on

Check the interactive Neurogene Stock chart to analyse performance

Neurogene stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$18.06
    Today's High:$18.84

    Day's Volatility :4.14%

  • 52 Weeks Low:$6.88
    52 Weeks High:$74.49

    52 Weeks Volatility :90.77%

Neurogene Stock Returns

PeriodNeurogene IncIndex (Russel 2000)
3 Months
3.72%
0.0%
6 Months
13.57%
0.0%
1 Year
-43.91%
0.0%
3 Years
254.04%
-4.7%

Neurogene Inc Key Stats

Check Neurogene key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$18.84
Open
$18.84
Today's High
$18.84
Today's Low
$18.06
Market Capitalization
$268.9M
Today's Volume
$95.0K
52 Week High
$74.49
52 Week Low
$6.875
Revenue TTM
$0.0
EBITDA
$-92.6M
Earnings Per Share (EPS)
$-4.31
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-39.41%

Stock Returns calculator for Neurogene Stock including INR - Dollar returns

The Neurogene stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Neurogene investment value today

Current value as on today

₹61,439

Returns

₹38,561

(-38.56%)

Returns from Neurogene Stock

₹43,845 (-43.85%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Neurogene Stock

-63%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Neurogene Stock from India on INDmoney has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Neurogene Stock

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Neurogene(by analysts ranked 0 to 5 stars)

Neurogene Share Price Target

What analysts predicted

Upside of 157.19%

Target:

$47.40

Current:

$18.43

Neurogene share price target is $47.40, a slight Upside of 157.19% compared to current price of $18.43 as per analysts' prediction.

Neurogene Stock Insights

  • Price Movement

    In the last 7 days, NGNE stock has moved down by -7.9%
  • NGNE vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 120.7%

Neurogene Technicals Summary

Sell

Neutral

Buy

Neurogene is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Neurogene Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Neurogene Inc logo
-15.47%
13.57%
-43.91%
254.04%
-71.05%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Neurogene Inc

Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreements with The University of Edinburgh, Virovek, Inc., Sigma-Aldrich Co. LLC., and Leland Stanford Junior University. The company was founded in 2018 and is headquartered in New York, New York.
Organization
Neurogene
Employees
107
CEO
Dr. Rachel L. McMinn Ph.D.
Industry
Miscellaneous

Key Management of Neurogene Inc

NameTitle
Dr. Rachel L. McMinn Ph.D.
Founder, Executive Chair & CEO
Ms. Christine Mikail Cvijic J.D.
President & CFO
Dr. Julie Jordan M.D.
Chief Medical Officer
Mr. Arvind Sreedharan
Senior Vice President of Business Operations
Dr. Stuart Cobb Ph.D.
Chief Scientific Officer
Ms. Donna M. Cochener-Metcalfe J.D.
Senior VP, General Counsel & Corporate Secretary
Dr. Effie Albanis M.D.
Senior Vice President of Early Clinical & Translational Research
Dr. Andrew E. Mulberg CPI, FAAP, M.D.
Senior Vice President of Regulatory Affairs, Quality Assurance & Quality Control
Mr. Ricardo Jimenez
Senior Vice President of Technical Operations

Important FAQs about investing in NGNE Stock from India :

What is Neurogene share price today?

Neurogene share price today is $18.43 as on at the close of the market. Neurogene share today touched a day high of $18.84 and a low of $18.06.

What is the 52 week high and 52 week low for Neurogene share?

Neurogene share touched a 52 week high of $74.49 and a 52 week low of $6.88. Neurogene stock price today i.e. is closed at $18.43, lower by 75.26% versus the 52 week high.

How to invest in Neurogene Stock (NGNE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Neurogene on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neurogene Shares that will get you 0.0814 shares as per Neurogene share price of $18.43 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Neurogene Stock (NGNE) from India?

Indian investors can start investing in Neurogene (NGNE) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Neurogene stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Neurogene share’s latest price of $18.43 as on August 30, 2025 at 1:29 am IST, you will get 0.5426 shares of Neurogene. Learn more about fractional shares .

What are the returns that Neurogene has given to Indian investors in the last 5 years?

Neurogene stock has given -71.05% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?